Are TWEAK and DcR3 molecular targets for the treatment of multiple sclerosis?

Mueller, A. M. and Pedre, X. and Steinbrecher, A. (2007) Are TWEAK and DcR3 molecular targets for the treatment of multiple sclerosis? MULTIPLE SCLEROSIS, 13 (Suppl2). S155-S156. ISSN 1352-4585

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 08 Dec 2020 07:44
Last Modified: 08 Dec 2020 07:44
URI: https://pred.uni-regensburg.de/id/eprint/32158

Actions (login required)

View Item View Item